دورية أكاديمية
Short-Term Effects of Whole-Body Photobiomodulation on Pain, Quality of Life and Psychological Factors in a Population Suffering from Fibromyalgia: A Triple-Blinded Randomised Clinical Trial.
| العنوان: | Short-Term Effects of Whole-Body Photobiomodulation on Pain, Quality of Life and Psychological Factors in a Population Suffering from Fibromyalgia: A Triple-Blinded Randomised Clinical Trial. |
|---|---|
| المؤلفون: | Navarro-Ledesma S; Department of Physiotherapy, Faculty of Health Sciences, University of Granada, Querol Street, 5, 52004, Melilla, Spain. snl@ugr.es., Carroll J; THOR Photomedicine Ltd., Amersham, UK., Burton P; THOR Photomedicine Ltd., Amersham, UK., Ana GM; Clínica Ana González, Malaga, Spain. |
| المصدر: | Pain and therapy [Pain Ther] 2023 Feb; Vol. 12 (1), pp. 225-239. Date of Electronic Publication: 2022 Nov 11. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634491 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8237 (Print) NLM ISO Abbreviation: Pain Ther Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2014- : [Auckland] Adis Original Publication: [London] : Springer Healthcare |
| مستخلص: | Background: Fibromyalgia (FM) is a multifunctional chronic musculoskeletal pain condition characterised by sensory hypersensitivity. Photobiomodulation (PBM) has shown a positive impact on relieving pain; however, no studies to our knowledge have analysed a whole-body PBM intervention in subjects with FM. The aims of the study were to compare the effects of whole-body PBM with placebo PBM on pain, functionality and psychological symptoms in patients suffering from FM. Methods: Forty-two subjects were recruited from a private care practice. The design of the study is a randomised, triple-blinded, placebo-controlled clinical trial. Participants received 12 treatment sessions. Pain, quality of life, level of physical activity and psychological factors were assessed at baseline (T0), after session 6 (T1), after treatment (T2) and at 2-week (T3) follow-up. Results: There were statistically significant differences in pain at 4 weeks (p ≤ 0.001) (T2) and the 2-week follow-up (T3) (p ≤ 0.001). In relation to the quality of life, there were statistically significant improvements after session 6 (p ≤ 0.001) (T1), immediately after treatment (p ≤ 0.001) (T2) and at the 2-week (T3) follow-up (p ≤ 0.001). Kinesiophobia presented significant differences between groups immediately after treatment (p ≤ 0.001) (T2) and at the 2-week (T3) follow-up (p ≤ 0.001), with self-efficacy only showing significant differences between groups 2 weeks after the treatment (p = 0.01) (T2). There were no differences between groups when comparing pain catastrophising at any time. Conclusion: Whole-body PBM resulted in a significant reduction in pain and an improvement in quality of life in those participants suffering from FM after receiving 4 weeks of treatment. Furthermore, psychological factors such as kinesiophobia and self-efficacy were also improved. Thus, a whole-body PBM treatment is presented as a possible new multifactorial treatment with potential benefits for those with FM and more studies are needed to corroborate our findings. Trial Registration: ClinicalTrials.gov (NCT0424897). (© 2022. The Author(s).) |
| References: | Ann Biomed Eng. 2012 Feb;40(2):516-33. (PMID: 22045511) Discov Med. 2011 Feb;11(57):154-9. (PMID: 21356170) J Clin Exp Dent. 2021 Jul 01;13(7):e724-e732. (PMID: 34306537) Pain Res Treat. 2012;2012:426130. (PMID: 23213512) J Pain. 2017 Sep;18(9):1139-1149. (PMID: 28528981) Semin Arthritis Rheum. 2016 Dec;46(3):319-329. (PMID: 27916278) PLoS One. 2015 May 15;10(5):e0126324. (PMID: 25978402) Lasers Med Sci. 2022 Jun;37(4):2123-2133. (PMID: 35122543) Front Sports Act Living. 2020 Apr 29;2:48. (PMID: 33345040) Pain. 1999 Nov;83(2):157-62. (PMID: 10534586) Curr Pain Headache Rep. 2013 Aug;17(8):356. (PMID: 23801009) Psychol Rev. 1977 Mar;84(2):191-215. (PMID: 847061) Brain Behav Immun Health. 2019 Dec 17;2:100028. (PMID: 38377418) Clin Exp Rheumatol. 2008 Jul-Aug;26(4):519-26. (PMID: 18799079) J Pain. 2011 Apr;12(4):425-35. (PMID: 20926355) Mol Neurobiol. 2018 Aug;55(8):6601-6636. (PMID: 29327206) J Physiother. 2020 Jul;66(3):155-165. (PMID: 32680739) Lancet. 2017 Sep 16;390(10100):1211-1259. (PMID: 28919117) JAMA. 2014 Apr 16;311(15):1547-55. (PMID: 24737367) Photobiomodul Photomed Laser Surg. 2019 Nov;37(11):681-693. (PMID: 31596658) J Lasers Med Sci. 2019 Winter;10(1):12-20. (PMID: 31360363) J Pain. 2008 Feb;9(2):105-21. (PMID: 18055266) Biomed Res Int. 2017;2017:2356346. (PMID: 29291206) Lasers Surg Med. 2003;32(3):233-8. (PMID: 12605431) FEBS Lett. 1984 Sep 17;175(1):95-9. (PMID: 6479342) J Pain. 2019 Jun;20(6):611-628. (PMID: 30453109) Disabil Rehabil. 2005 Jun 17;27(12):695-701. (PMID: 16012062) J Photochem Photobiol B. 2005 Nov 1;81(2):98-106. (PMID: 16125966) Int J Mol Sci. 2021 Apr 09;22(8):. (PMID: 33918736) Pain Physician. 2019 May;22(3):241-254. (PMID: 31151332) Lasers Med Sci. 2020 Apr;35(3):513-522. (PMID: 30982176) J Pain. 2021 Jul;22(7):763-777. (PMID: 33636371) Braz J Phys Ther. 2021 Mar-Apr;25(2):168-174. (PMID: 32487449) BMC Sports Sci Med Rehabil. 2021 Aug 14;13(1):91. (PMID: 34391447) Pain Res Manag. 2018 Oct 1;2018:2930632. (PMID: 30402199) Pain Manag Nurs. 2021 Oct;22(5):571-578. (PMID: 34215527) Neural Regen Res. 2021 Jun;16(6):1177-1185. (PMID: 33269767) Pilot Feasibility Stud. 2016 Oct 21;2:64. (PMID: 27965879) Adv Rheumatol. 2021 Oct 16;61(1):62. (PMID: 34656170) Pain. 2001 Nov;94(2):149-158. (PMID: 11690728) BMC Geriatr. 2016 Jul 07;16:128. (PMID: 27387557) Medicina (Kaunas). 2019 Jun 01;55(6):. (PMID: 31159453) Support Care Cancer. 2020 May;28(5):2485-2498. (PMID: 32080767) Lasers Med Sci. 2014 Nov;29(6):1967-76. (PMID: 24942380) Dose Response. 2011;9(4):602-18. (PMID: 22461763) Health Qual Life Outcomes. 2005 Nov 14;3:71. (PMID: 16285884) Open Orthop J. 2013 Sep 20;7:396-419. (PMID: 24155802) J Clin Epidemiol. 2010 Aug;63(8):e1-37. (PMID: 20346624) Eur J Phys Rehabil Med. 2019 Apr;55(2):301-313. (PMID: 30698402) Ther Adv Chronic Dis. 2022 Feb 21;13:20406223221078095. (PMID: 35222905) Front Psychol. 2018 Mar 22;9:377. (PMID: 29623059) Psychol Res Behav Manag. 2019 Feb 13;12:117-127. (PMID: 30858740) |
| فهرسة مساهمة: | Keywords: Chronic pain; Fibromyalgia; Kinesiophobia; Pain; Pain catastrophising; Photobiomodulation; Psychological factors; Quality of life; Self-efficacy |
| سلسلة جزيئية: | ClinicalTrials.gov NCT0424897 |
| تواريخ الأحداث: | Date Created: 20221112 Latest Revision: 20240911 |
| رمز التحديث: | 20240911 |
| مُعرف محوري في PubMed: | PMC9845459 |
| DOI: | 10.1007/s40122-022-00450-5 |
| PMID: | 36369323 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder كن أول من يترك تعليقا!